Target expression details
Target's General Information | |||||
---|---|---|---|---|---|
Target ID | T86014 | ||||
Target Name | Sphingosine kinase 1 (SPHK1) | ||||
Synonyms | SPK 1; SPK; SPHK1; SK 1; Acetyltransferase SPHK1 | ||||
Target Type | Clinical trial | ||||
Gene Name | SPHK1 | ||||
Biochemical Class | Kinase | ||||
UniProt ID | SPHK1_HUMAN | ||||
Target's Expression Profile in Disease Related Tissue between Patients and Normal People | |||||
Disease | Arteriosclerosis | ||||
Example drug | F-12509A | Terminated | [1], [2], [3] | ||
Tissue | Peripheral blood | ||||
Level of differential expression between the patients in the disease section of the tissue and the tissues of healthy individual |
Fold-change: -0.01 Z-score: -0.06 P-value: 7.48E-01 |
||||
Target gene expression profiles of the patients in the disease section of the tissue
Target gene expression profiles in the tissue of healthy individual
|
|||||
Target's Expression Profile across Various Tissues of Healthy Individual | |||||
References | |||||
REF 1 | F-12509A, a new sphingosine kinase inhibitor, produced by a discomycete. J Antibiot (Tokyo). 2000 May;53(5):459-66. | ||||
REF 2 | Interpreting expression profiles of cancers by genome-wide survey of breadth of expression in normal tissues. Genomics 2005 Aug;86(2):127-41. | ||||
REF 3 | NCBI GEO: archive for functional genomics data sets--update. Nucleic Acids Res. 2013 Jan;41(Database issue):D991-5. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.